Severe impairment of quality of life in Hailey-Hailey disease

Acta Dermato-Venereologica

Volumn 85, Issue 2, 2005, Pages 132-135

  Gisondi, Paolo ^a   Sampogna, Francesca ^a   Annessi, Giorgio ^a   Girolomoni, Giampiero ^a   Abeni, Damiano ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Familial benign chronic pemphigus; Hailey Hailey disease; Quality of life; Skin diseases

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DISABILITY; DISEASE COURSE; DISTRESS SYNDROME; EMOTION; FEMALE; HAILEY HAILEY DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SOCIAL STATUS; SYMPTOMATOLOGY;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS, BENIGN FAMILIAL; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 16444363700     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410025462     Document Type: Article

References (22)

1. Hailey H, Hailey H. Familial benign chronic pemphigus. Arch Dermatol Syphilol 1939; 39: 679-685.
2. 2+ pump. Hum Mol Genet 2000; 9: 1131-1140.
3. Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, Ogawa H, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet 2000; 24: 61-65.
4. Burge SM. Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 1992; 126: 275-282.
5. Sand C, Thomsen HK. Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. Arch Dermatol 2003; 139: 1401-1402.
6. Rabeni EJ, Cunningham NM. Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol 2002; 47: 797-798.
7. Ruiz-Rodriguez R, Alvarez JG, Jaen P, Acevedo A, Cordoba S. Photodynamic therapy with 5-aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey-Hailey disease). J Am Acad Dermatol 2002; 47: 740-742.
8. Kang NG, Yoon TJ, Kim TH. Botulinum toxin type A as an effective adjuvant therapy for Hailey-Hailey disease. Dermatol Surg 2002; 28: 543.
9. Lapiere JC, Hirsh A, Gordon KB, Cook B, Montalvo A. Botulinum toxin type A for the treatment of axillary Hailey-Hailey disease. Dermatol Surg 2000; 26: 371-374.
10. Harris A, Burge SM, Dykes PJ, Finlay AY. Handicap in Darier's disease and Hailey-Hailey disease. Br J Dermatol 1996; 135: 959-963.
11. Boulinguez S. Les échelles de qualité de vie. Ann Dermatol Venereol 2000; 1247: 2S5-2S6.
12. Chren M, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-1440.
13. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002; 204: 43-49.
14. Abeni D, Picardi A, Puddu P, Pasquini P, Chren M. Lo skindex-29, un nuovo strumento per la valutazione della qualità della vita in dermatologia. G Ital Dermatol Venereol 2001; 136: 73-76.
15. Picardi A, Abeni D, Pasquini P. Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol 2001; 15: 410-417.
16. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use, 2nd edn. Oxford: Oxford University Press, 1995.
17. Sampogna F, Picardi A, Melchi CF, Pasquini P, Abeni D. The impact of skin diseases on patients: comparing dermatologists' opinions with research data collected on their patients. Br J Dermatol 2003; 148: 989-995.
18. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
19. Gobello T, Mazzanti C, Sordi D, Annessi G, Abeni D, Chinni LM, et al. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003; 49: 679-684.
20. Renzi C, Picardi A, Abeni D, Agostini E, Baliva G, Pasquini P, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 2002; 138: 337-342.
21. Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752-756.
22. Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exp Dermatol 1987; 12: 8-11.